ScreenerHero

RTALBRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

BIST · TR · Healthcare · Biotechnology · rtalabs.com.tr
2.960TRY+0.68%Mkt Cap: 35.39M $P/E: 4.93

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nuclei…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap35.39M $
Enterprise Value33.74M $
Revenue (TTM)6.83M $
Gross Profit1.98M $
Net Income (TTM)21.07M $
Revenue/Share0.0115 USD
Last Price2.960 TRY
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees81
CountryTR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)4.93
P/E (Forward)—
PEG—
EV/EBITDA126.79
EV/Revenue4.94
P/S5.15
P/B0.50
EPS (TTM)0.60
EPS (Forward)—
52W Range
2.7808% of range5.080
52W High5.080 TRY
52W Low2.780 TRY
Profitability
Gross Margin34.60%
Oper. Margin-26.34%
EBITDA Margin3.90%
Profit Margin367.83%
ROE29.72%
ROA25.66%
Growth
Revenue Growth45.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.69M $
CapEx (TTM)799.20K $
FCF Margin-24.18%
FCF Yield-4.67%
Net Debt-1.42M $
Net Debt/EBITDA-5.32
Balance Sheet
Debt/Equity0.04
Current Ratio4.80
Quick Ratio3.68
Book Value/Sh5.930 TRY
Cash/Share0.1620 TRY
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 TRY
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split500:100
Split DateMar 19, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.500.00M
Float350.00M
Insiders16.59%
Institutions0.03%
Technical
SMA 503.316 (-10.7%)
SMA 2003.652 (-19.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)19.68M
Avg Vol (10d)20.36M
Technical Indicators
RSI (14)39.8
MACD-0.1148
MACD Signal-0.1318
MACD Hist.+0.0170
BB Upper3.276 TRY
BB Middle3.012 TRY
BB Lower2.748 TRY
BB Width17.55%
ATR (14)0.1165 TRY
Vol Ratio (20d)1.06x